Key facts
- This page summarizes Pillar Invest Corp's Form 4 filing for Aceragen, Inc..
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 19 Jul 2023, 16:05.
Pillar Invest Corp - 12 Jul 2023 Form 4 Insider Report for Aceragen, Inc.
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- N/A
- Reported as of
- 12 Jul 2023
- Net transaction value
- -$9,104
- SEC form
- 4
- Accepted by SEC
- 19 Jul 2023, 16:05:10 UTC
- Prior SEC filing
- 19 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- Pillar Invest Corporation, /s/ Youssef El Zein, Authorized Person
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Pillar Invest Corp filed Form 4 for Aceragen, Inc. on 19 Jul 2023.
Change
- Previous filing in this sequence was filed on 19 Jul 2023.
- Current net transaction value: -$9,104.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ACGN
transaction
Common Stock
Sale
- Transaction value
- $5,696
- Shares
- -3,605
- Change %
- -2.1%
- Price
- $1.58
- Shares after
- 167,107
- Date
- 12 Jul 2023
- Ownership
- By Abude Umari See Footnote
- Footnotes
- F1
ACGN
transaction
Common Stock
Sale
- Transaction value
- $3,408
- Shares
- -2,213
- Change %
- -1.3%
- Price
- $1.54
- Shares after
- 164,894
- Date
- 13 Jul 2023
- Ownership
- By Abude Umari See Footnote
- Footnotes
- F1
ACGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 355,247
- Date
- 12 Jul 2023
- Ownership
- By Pillar Partners Foundation, L.P. See Footnote
- Footnotes
- F1
ACGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 135,540
- Date
- 12 Jul 2023
- Ownership
- By Pillar Pharmaceuticals 6, L.P. See Footnote
- Footnotes
- F1
ACGN
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,547
- Date
- 12 Jul 2023
- Ownership
- By Youssef El Zein See Footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.
SEC remarks
Mr. Umari's 29,965 shares of the Issuer's Common Stock purchased on May 17, 2023 are matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with Mr. Umari's sales of 3,605 shares of the Issuer's Common Stock on July 12, 2023 and of 2,213 shares of the Issuer's Common Stock on July 13, 2023. Mr. Umari has made arrangements with the Issuer to voluntarily disgorge $842.36 to the Issuer, which represents the full amount of Mr. Umari's short-swing profit realized from the matchable transactions as calculated pursuant to Section 16(b).